HEARTSCIENCES INC. news, videos and press releases - Page 2
For more news please use our advanced search feature.
HEARTSCIENCES INC. - More news...
HEARTSCIENCES INC. - More news...
- HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting
- HeartSciences Reports Second Quarter Fiscal 2024 Financial Results
- HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway
- HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms
- HeartSciences’ MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers
- HeartSciences Issues Investor Update Highlighting Recent Key Achievements and Positive Developments
- HeartSciences Receives Two New Patent Allowances, Expanding its International Patent Portfolio
- HeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I.
- HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms
- HeartSciences Reports First Quarter Fiscal 2024 Financial Results
- HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase
- HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards
- HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India
- HeartSciences Signs Distribution Agreement with FJ Medical, Denmark
- HeartSciences’ MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation
- HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio
- MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark
- HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results
- HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine
- HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG
- HeartSciences to Participate at the Inaugural EF Hutton Global Conference
- HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference
- HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023
- HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results
- HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time
- HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease
- HeartSciences Announces Further Internationalization of its Patent Portfolio
- Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th
- HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th
- HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance Executive
